4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-005582
Matsuda Masaru sold 40,638 shares at an average $25.28 ($1,027,293)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form 10b5-1 | −7,983 | $25.50 | $203,554 | 142,658 | D |
| 2026-02-02 | Sale : show line 2 in the form 10b5-1 | −8,562 | $24.97 | $213,793 | 134,096 | D |
| 2026-02-02 | Sale : show line 3 in the form 10b5-1 | −19,379 | $25.24 | $489,126 | 114,717 | D |
| 2026-02-02 | Sale : show line 4 in the form 10b5-1 | −4,714 | $25.63 | $120,820 | 110,003 | D |
| Open-market sales · 40,638 sh · avg $25.28 · $1,027,293 | ||||||
Loading xslF345X05/wk-form4_1770255345.xml…